Engineered myocardial tissues constructed <Emphasis Type="Italic">in vivo</Emphasis> using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats
(1) Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, 710032, China
Abstract:
Background
To explore the feasibility of constructing engineered myocardial tissues (EMTs) in vivo, using polylactic acid -co-glycolic acid (PLGA) for scaffold and cardiomyocyte-like cells derived from bone marrow mesenchymal
stem cells (BMMSCs) for seeded cells.